Summary: A comprehensive review of recent genetic and population studies finds that premorbid cognitive deficits associated with schizophrenia — including lower IQ and early cognitive difficulties — are driven largely by neurodevelopmental disruptions rather than by the same inherited genetic variants that directly increase schizophrenia risk.
The review argues that non-familial influences, such as rare genetic mutations that arise de novo and certain environmental factors, make a substantial contribution to both early cognitive impairment and elevated schizophrenia risk. This conclusion challenges the longstanding assumption that the cognitive deficits seen before psychosis share common genetic origins with the disorder itself.
These insights point to the importance of studying early brain development and the non-heritable events that can derail it, as a path toward preventing or reducing both cognitive impairment and the later emergence of schizophrenia.
Key Facts:
- Premorbid cognitive deficits in schizophrenia are predominantly linked to neurodevelopmental disruption rather than inherited, familial genetics.
- Non-familial contributors — including rare de novo genetic variants and environmental exposures — appear to be major drivers of both cognitive impairment and schizophrenia vulnerability.
- Focusing on neurodevelopmental mechanisms could improve early prevention and intervention strategies for cognitive difficulties and schizophrenia.
Source: Genomic Press
Overview of the review
In an extensive review of genetic and population research published in the peer‑reviewed journal Genomic Psychiatry, Professors Michael Owen and Michael O’Donovan from Cardiff University’s Centre for Neuropsychiatric Genetics and Genomics evaluate the evidence connecting cognition and schizophrenia. Their analysis indicates that the cognitive deficits observed before the onset of psychosis are better explained by early neurodevelopmental disturbances than by the common inherited genetic variants that are associated with schizophrenia in family studies.
“For decades, the prevailing view was that the same genetic influences that increase schizophrenia risk also cause the premorbid cognitive problems often seen in patients,” Professor Owen explains. “Our synthesis of the latest studies suggests a different picture: both cognitive impairment and schizophrenia risk frequently stem from early neurodevelopmental disturbances driven by non-familial factors.”
Professor O’Donovan adds: “Recognizing that non‑familial events — including rare genetic changes and environmental insults during development — are central to these outcomes redirects where we should look for causes and, ultimately, where we should target prevention and remediation efforts.”
Key findings summarized by the authors include the following.
- Premorbid cognitive impairment is an indicator of underlying neurodevelopmental disruption that increases the likelihood of developing schizophrenia, but cognitive impairment alone does not directly cause the disorder.
- An individual’s cognitive performance relative to expectations from family history (that is, deviation from familial cognitive ability) is a stronger marker of an underlying neurodevelopmental disturbance than raw cognitive scores alone.
- The neurodevelopmental disturbances implicated do not appear to be driven mainly by the same inherited common genetic variants that broadly influence cognitive ability in the general population or that raise familial schizophrenia risk. Instead, rare genetic events — such as copy number variations (CNVs) and damaging coding mutations that occur de novo — alongside non-familial environmental exposures, play a notable role.
- There is evidence that some individuals experience further cognitive decline after a schizophrenia diagnosis and that people with schizophrenia face an elevated risk of dementia; however, this later decline does not seem principally attributable to inherited genetic risk for classical neurodegenerative disease.
Based on these observations, the researchers propose a model in which early neurodevelopmental perturbations — often influenced by non‑familial genetic and environmental factors — create a shared vulnerability that manifests as cognitive impairment and raises risk for schizophrenia. Rather than supporting a sharply defined “neurodevelopmental subtype” of schizophrenia, the findings favor a continuum model in which the extent and timing of developmental disruption determine the severity and combination of cognitive and psychotic outcomes.
Implications for research and clinical practice are significant. If non‑familial neurodevelopmental insults are primary drivers, then identifying the specific rare genetic events and environmental risks that disrupt brain development could open windows for prevention, early detection and targeted interventions. Investments in developmental neuroscience, population cohort studies, and genetic analyses that capture rare variants will be particularly important.
The authors also call for more research into why some people with schizophrenia experience progressive cognitive decline and a higher incidence of dementia. Understanding whether these later changes reflect distinct biological processes, treatment effects, lifestyle factors, or interactions among those elements is essential for designing strategies to preserve cognitive function across the lifespan.
This review advances our understanding of the complex relationships among genetics, brain development, cognition and psychosis. By highlighting the dominant role of non-familial, developmentally timed factors, it sets a clear agenda for future studies aiming to prevent or reduce the cognitive and clinical burdens associated with schizophrenia.
About this schizophrenia and cognition research news
Author: Ma-Li Wong
Source: Genomic Press
Contact: Ma-Li Wong – Genomic Press
Image: The image is credited to Neuroscience News
Original Research: Open access. “The genetics of cognition in schizophrenia” by Michael Owen et al. Genomic Psychiatry